IONIQ’s new LUNA3 is a Winner
Salt Lake City, UT, July 1, 2022 – ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the “Company”) today announced that it has won the ‘2022 Innovation Award’ in the Medical & Health category. The Innovation Award is a prestigious competition and award from Utah Business Magazine in partnership with Stoel Rives LLP.
Jared Bauer, IONIQ Sciences CEO, triumphantly shared, “Thank you to Utah Business Magazine and the esteemed panel of judges for recognizing the profound impact that our LUNA3™ next-generation platform can have for those at-risk of cancer. I am incredibly proud of our team of passionate problem-solvers who have already made a tremendous impact on our journey to modernize early-stage cancer detection.”
About IONIQ Sciences, Inc.
IONIQ Sciences, Inc. is developing an advanced multi-cancer screening technology for early detection that has the potential to expand the therapeutic window, dramatically improve survivability and reduce the cost of healthcare. IONIQ Sciences operates at the confluence of its Electrical Impedance Analytics (EIA) or bioimpedance technology and Artificial Intelligence (AI). IONIQ Science’s first product utilizing its proprietary analytic platform, the IONIQ ProLung Test™ for lung cancer, has been designated a Breakthrough Device by the U.S. FDA.
About BioHive
IONIQ Sciences is proud to be a key supporter and member of the newly formed BioHive, a collective representing the life science and healthcare innovation ecosystem. By embracing diversity and collaboration, BioHive has become the fastest-growing life science community in America and their innovations are improving the lives of millions of patients. To learn more, please visit: www.biohive.com.
For further information about IONIQ Sciences, Inc., please contact:
Andy Robertson | 1-801-736-0729 | acr@IONIQsciences.com
IONIQ Sciences, Vice President of Business Development
IONIQ Sciences, Inc.
350 W. 800 N., Suite 214
Salt Lake City, Utah 84103
USA
www.IONIQsciences.com
Follow IONIQ Sciences, Inc. on Twitter, Facebook, Instagram and LinkedIn: @IONIQSciences